Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $143B | +$543M | 247 | 3.54% | Increased |
|
| 2 |
BlackRock
New York
| $134B | +$2.57B | 270 | 3.76% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $79.2B | +$1.04B | 255 | 4.19% | Increased |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $36.1B | -$28.7M | 66 | 6.14% | Reduced |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $32.7B | -$1.14B | 173 | 2.6% | Reduced |
|
| 6 |
Geode Capital Management
Boston,
Massachusetts
| $28.1B | +$736M | 279 | 3.79% | Increased |
|
| 7 |
T. Rowe Price Associates
Baltimore,
Maryland
| $25.7B | +$1.17B | 134 | 2.42% | Increased |
|
| 8 |
JP Morgan Chase
New York
| $24.3B | +$520M | 222 | 3% | Increased |
|
| 9 |
Capital World Investors
Los Angeles,
California
| $22.3B | -$300M | 26 | 3.81% | Reduced |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $20.9B | +$603M | 239 | 3.7% | Increased |
|
| 11 |
Bank of America
Charlotte,
North Carolina
| $19.7B | +$45.3M | 259 | 2.04% | Increased |
|
| 12 |
Capital International Investors
Los Angeles,
California
| $19.3B | -$525M | 24 | 4.41% | Reduced |
|
| 13 |
Morgan Stanley
New York
| $18.2B | +$421M | 293 | 2.45% | Increased |
|
| 14 |
Bank of New York Mellon
New York
| $17.8B | -$129M | 212 | 3.47% | Reduced |
|
| 15 |
Capital Research Global Investors
Los Angeles,
California
| $17.2B | -$460M | 11 | 4.02% | Reduced |
|
| 16 |
Norges Bank
Oslo,
Norway
| $17B | +$408M | 70 | 3.76% | Increased |
|
| 17 |
BBA
Baker Bros. Advisors
New York
| $16.1B | +$53.6M | 43 | 70.78% | Increased |
|
| 18 |
Franklin Resources
San Mateo,
California
| $14.6B | +$679M | 85 | 5.5% | Increased |
|
| 19 |
Primecap Management
Pasadena,
California
| $13.1B | -$189M | 19 | 9.27% | Reduced |
|
| 20 |
Charles Schwab
San Francisco,
California
| $12.8B | +$464M | 177 | 4.18% | Increased |
|
| 21 |
Wells Fargo
San Francisco,
California
| $12.4B | -$249M | 255 | 2.73% | Reduced |
|
| 22 |
Invesco
Atlanta,
Georgia
| $11.4B | +$1.47B | 140 | 2.88% | Increased |
|
| 23 |
Legal & General Group
London,
United Kingdom
| $11.3B | +$636M | 177 | 3.66% | Increased |
|
| 24 |
Dodge & Cox
San Francisco,
California
| $11.3B | +$1.23B | 11 | 7.34% | Increased |
|
| 25 |
Goldman Sachs
New York
| $10.3B | +$888M | 196 | 2.19% | Increased |
|